Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mantle Irradiation for Selected Hodgkin's Disease Patients With Stage IA-IIA Disease

NCT00165269 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT00165269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00165269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mantle Irradiation for Selected Hodgkin's Disease Patients With Stage IA-IIA Disease
Lead sponsor
Dana-Farber Cancer Institute
Phase
Phase 2
Overall status
Completed
Start date
May 31, 1992
Completion date
February 29, 2008
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin's disease